Implantable drug infusion system


May 2019

The report presents a summary of reimbursement situation report for implantable drug infusion systems for chronic pain. The following indications will be considered: post-laminectomy syndrome, low back pain, complex regional pain syndrome, neoplasm related pain. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. Read more